{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:44:44Z","timestamp":1790754284060,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T00:00:00Z","timestamp":1647216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T00:00:00Z","timestamp":1647216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172283"],"award-info":[{"award-number":["82172283"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1038\/s41429-022-00515-9","type":"journal-article","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T10:02:52Z","timestamp":1647252172000},"page":"287-295","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Inhibition of Staphylococcus aureus and biofilm formation by the anthelminthic drug, triclabendazole"],"prefix":"10.1038","volume":"75","author":[{"given":"Jie","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duoyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengchun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zewen","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,14]]},"reference":[{"key":"515_CR1","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1128\/CMR.00134-14","volume":"28","author":"SY Tong","year":"2015","unstructured":"Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG Jr. Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28:603\u201361.","journal-title":"Clin Microbiol Rev"},{"key":"515_CR2","doi-asserted-by":"publisher","first-page":"7.2.18","DOI":"10.1128\/microbiolspec.GPP3-0057-2018","volume":"7","author":"M Vestergaard","year":"2019","unstructured":"Vestergaard M, Frees D, Ingmer H. Antibiotic resistance and the MRSA problem. Microbiol Spectr. 2019;7:7.2.18.","journal-title":"Microbiol Spectr"},{"key":"515_CR3","doi-asserted-by":"publisher","first-page":"e00026","DOI":"10.1128\/MMBR.00026-19","volume":"84","author":"K Schilcher","year":"2020","unstructured":"Schilcher K, Horswill AR. Staphylococcal biofilm development: Structure, regulation, and treatment strategies. Microbiol Mol Biol Rev. 2020;84:e00026\u201319.","journal-title":"Microbiol Mol Biol Rev"},{"key":"515_CR4","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/femsre\/fux010","volume":"41","author":"CW Hall","year":"2017","unstructured":"Hall CW, Mah TF. Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria. FEMS Microbiol Rev. 2017;41:276\u2013301.","journal-title":"FEMS Microbiol Rev"},{"key":"515_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15966-7","volume":"11","author":"F Peyrusson","year":"2020","unstructured":"Peyrusson F, Varet H, Nguyen TK, Legendre R, Sismeiro O, Copp\u00e9e JY, et al. Intracellular Staphylococcus aureus persisters upon antibiotic exposure. Nat Commun. 2020;11:2200.","journal-title":"Nat Commun"},{"key":"515_CR6","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1128\/AAC.02073-12","volume":"57","author":"W Abdelhady","year":"2013","unstructured":"Abdelhady W, Bayer AS, Seidl K, Nast CC, Kiedrowski MR, Horswill AR, et al. Reduced vancomycin susceptibility in an in vitro catheter-related biofilm model correlates with poor therapeutic outcomes in experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrobial Agents Chemother. 2013;57:1447\u201354.","journal-title":"Antimicrobial Agents Chemother"},{"key":"515_CR7","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.tig.2019.03.007","volume":"35","author":"D Wilmaerts","year":"2019","unstructured":"Wilmaerts D, Windels EM, Verstraeten N, Michiels J. General mechanisms leading to persister formation and awakening. Trends Genet: Tig. 2019;35:401\u201311.","journal-title":"Trends Genet: Tig"},{"key":"515_CR8","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.3390\/microorganisms9081697","volume":"9","author":"H Pi","year":"2021","unstructured":"Pi H, Ogunniyi AD, Savaliya B, Nguyen HT, Page SW, Lacey E, et al. Repurposing of the fasciolicide triclabendazole to treat infections caused by staphylococcus spp. and vancomycin-resistant enterococci. Microorganisms. 2021;9:1697.","journal-title":"Microorganisms."},{"key":"515_CR9","volume-title":"Performance standards for antimicrobial susceptibility testing: 24th Informational supplement","author":"Institute CaLS","year":"2016","unstructured":"Institute CaLS. Performance standards for antimicrobial susceptibility testing: 24th Informational supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2016. Document M100-S26"},{"key":"515_CR10","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1021\/acsinfecdis.1c00030","volume":"7","author":"J Zheng","year":"2021","unstructured":"Zheng J, Shang Y, Wu Y, Wu J, Chen J, Wang Z, et al. Diclazuril inhibits biofilm formation and hemolysis of Staphylococcus aureus. ACS Infect Dis. 2021;7:1690\u2013701.","journal-title":"ACS Infect Dis."},{"key":"515_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.micpath.2018.08.021","volume":"124","author":"X Sun","year":"2018","unstructured":"Sun X, Lin ZW, Hu XX, Yao WM, Bai B, Wang HY, et al. Biofilm formation in erythromycin-resistant Staphylococcus aureus and the relationship with antimicrobial susceptibility and molecular characteristics. Micro Pathog. 2018;124:47\u201353.","journal-title":"Micro Pathog"},{"key":"515_CR12","doi-asserted-by":"publisher","first-page":"6076","DOI":"10.1128\/AEM.70.10.6076-6085.2004","volume":"70","author":"E Charpentier","year":"2004","unstructured":"Charpentier E, Anton AI, Barry P, Alfonso B, Fang Y, Novick RP. Novel cassette-based shuttle vector system for gram-positive bacteria. Appl Environ Microbiol. 2004;70:6076\u201385.","journal-title":"Appl Environ Microbiol"},{"key":"515_CR13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1099\/jmm.0.001122","volume":"69","author":"JX Zheng","year":"2020","unstructured":"Zheng JX, Tu HP, Sun X, Xu GJ, Chen JW, Deng QW, et al. In vitro activities of telithromycin against Staphylococcus aureus biofilms compared with azithromycin, clindamycin, vancomycin and daptomycin. J Med Microbiol. 2020;69:120\u201331.","journal-title":"J Med Microbiol"},{"key":"515_CR14","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/448645a","volume":"448","author":"CR Chong","year":"2007","unstructured":"Chong CR, Sullivan DJ Jr. New uses for old drugs. Nature. 2007;448:645\u20136.","journal-title":"Nature."},{"key":"515_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, et al. Drug repurposing: Progress, challenges, and recommendations. Nat Rev Drug Discov. 2019;18:41\u201358.","journal-title":"Nat Rev Drug Discov"},{"key":"515_CR16","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1093\/trstmh\/trz093","volume":"113","author":"P Gandhi","year":"2019","unstructured":"Gandhi P, Schmitt EK, Chen CW, Samantray S, Venishetty VK, Hughes D. Triclabendazole in the treatment of human fascioliasis: A review. Trans R Soc Tropical Med Hyg. 2019;113:797\u2013804.","journal-title":"Trans R Soc Tropical Med Hyg"},{"key":"515_CR17","doi-asserted-by":"crossref","unstructured":"Thakare R, Dasgupta A, Chopra S Triclabendazole for the treatment of fascioliasis. Drugs Today (Barc, Spain: 1998). 2019;55:743\u201352.","DOI":"10.1358\/dot.2019.55.12.3058861"},{"key":"515_CR18","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/nrmicro.2017.99","volume":"15","author":"H Koo","year":"2017","unstructured":"Koo H, Allan RN, Howlin RP, Stoodley P, Hall-Stoodley L. Targeting microbial biofilms: Current and prospective therapeutic strategies. Nat Rev Microbiol. 2017;15:740\u201355.","journal-title":"Nat Rev Microbiol"},{"key":"515_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11259-007-9000-3","volume":"32","author":"N Mestorino","year":"2008","unstructured":"Mestorino N, Formentini EA, Lucas MF, Fernandez C, Modamio P, Hern\u00e1ndez EM, et al. Pharmacokinetic disposition of triclabendazole in cattle and sheep; discrimination of the order and the rate of the absorption process of its active metabolite triclabendazole sulfoxide. Vet Res Commun. 2008;32:21\u201333.","journal-title":"Vet Res Commun"},{"key":"515_CR20","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1128\/AAC.04465-14","volume":"59","author":"K Arita-Morioka","year":"2015","unstructured":"Arita-Morioka K, Yamanaka K, Mizunoe Y, Ogura T, Sugimoto S. Novel strategy for biofilm inhibition by using small molecules targeting molecular chaperone DnaK. Antimicrobial Agents Chemother. 2015;59:633\u201341.","journal-title":"Antimicrobial Agents Chemother"},{"key":"515_CR21","doi-asserted-by":"publisher","first-page":"e00123","DOI":"10.1128\/mBio.00123-21","volume":"12","author":"A Fay","year":"2021","unstructured":"Fay A, Philip J, Saha P, Hendrickson RC, Glickman MS, Burns-Huang K. The DnaK chaperone system buffers the fitness cost of antibiotic resistance mutations in mycobacteria. mBio. 2021;12:e00123\u201021.","journal-title":"mBio."},{"key":"515_CR22","doi-asserted-by":"publisher","first-page":"e64337","DOI":"10.1371\/journal.pone.0064337","volume":"8","author":"YJ Lee","year":"2013","unstructured":"Lee YJ, Shi R, Witt SN. The small molecule triclabendazole decreases the intracellular level of cyclic AMP and increases resistance to stress in Saccharomyces cerevisiae. PLoS ONE. 2013;8:e64337.","journal-title":"PLoS ONE"},{"key":"515_CR23","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1042\/BST0380395","volume":"38","author":"DJ Sherratt","year":"2010","unstructured":"Sherratt DJ, Arciszewska LK, Crozat E, Graham JE, Grainge I. The Escherichia coli DNA translocase FtsK. Biochemical Soc Trans. 2010;38:395\u20138.","journal-title":"Biochemical Soc Trans"},{"key":"515_CR24","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/j.1365-2958.2009.06892.x","volume":"74","author":"LJ Wu","year":"2009","unstructured":"Wu LJ. It takes two DNA translocases to untangle chromosomes from the division septum. Mol Microbiol. 2009;74:773\u20136.","journal-title":"Mol Microbiol"},{"key":"515_CR25","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/mmi.13572","volume":"103","author":"H Veiga","year":"2017","unstructured":"Veiga H, Pinho MG. Staphylococcus aureus requires at least one FtsK\/SpoIIIE protein for correct chromosome segregation. Mol Microbiol. 2017;103:504\u201317.","journal-title":"Mol Microbiol"},{"key":"515_CR26","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.1016\/j.bmc.2004.07.031","volume":"12","author":"LD Jennings","year":"2004","unstructured":"Jennings LD, Foreman KW, Rush TS, Tsao DH, Mosyak L, Kincaid SL, et al. Combinatorial synthesis of substituted 3-(2-indolyl)piperidines and 2-phenyl indoles as inhibitors of ZipA-FtsZ interaction. Bioorg Medicinal Chem. 2004;12:5115\u201331.","journal-title":"Bioorg Medicinal Chem"},{"key":"515_CR27","doi-asserted-by":"publisher","first-page":"11821","DOI":"10.1073\/pnas.0404439101","volume":"101","author":"DN Margalit","year":"2004","unstructured":"Margalit DN, Romberg L, Mets RB, Hebert AM, Mitchison TJ, Kirschner MW, et al. Targeting cell division: Small-molecule inhibitors of FtsZ GTPase perturb cytokinetic ring assembly and induce bacterial lethality. Proc Natl Acad Sci USA. 2004;101:11821\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"515_CR28","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1021\/jm1012006","volume":"54","author":"K Kumar","year":"2011","unstructured":"Kumar K, Awasthi D, Lee SY, Zanardi I, Ruzsicska B, Knudson S, et al. Novel trisubstituted benzimidazoles, targeting Mtb FtsZ, as a new class of antitubercular agents. J Medicinal Chem. 2011;54:374\u201381.","journal-title":"J Medicinal Chem"},{"key":"515_CR29","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1039\/C7MD00387K","volume":"8","author":"N Sun","year":"2017","unstructured":"Sun N, Zheng YY, Du RL, Cai SY, Zhang K, So LY, et al. New application of tiplaxtinin as an effective FtsZ-targeting chemotype for an antimicrobial study. MedChemComm. 2017;8:1909\u201313.","journal-title":"MedChemComm."},{"key":"515_CR30","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1099\/mic.0.2007\/009506-0","volume":"153","author":"VK Singh","year":"2007","unstructured":"Singh VK, Utaida S, Jackson LS, Jayaswal RK, Wilkinson BJ, Chamberlain NR. Role for dnaK locus in tolerance of multiple stresses in Staphylococcus aureus. Microbiology. 2007;153:3162\u201373.","journal-title":"Microbiology"},{"key":"515_CR31","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.pt.2016.03.002","volume":"32","author":"JM Kelley","year":"2016","unstructured":"Kelley JM, Elliott TP, Beddoe T, Anderson G, Skuce P, Spithill TW. Current Threat of Triclabendazole Resistance in Fasciola hepatica. Trends Parasitol. 2016;32:458\u201369.","journal-title":"Trends Parasitol"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41429-022-00515-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-022-00515-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-022-00515-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T04:03:09Z","timestamp":1649217789000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41429-022-00515-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,14]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["515"],"URL":"https:\/\/doi.org\/10.1038\/s41429-022-00515-9","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,14]]},"assertion":[{"value":"22 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of Shenzhen Nanshan people\u2019s Hospital, the 6th Affiliated Hospital of Shenzhen University Health Science Center. For this type of study, formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}